Last October, the U.S. Food and Drug Administration (FDA) approved Trikafta to treat cystic fibrosis (CF). The drug’s maker, Vertex Pharmaceuticals, was already riding high on clinical trial data ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback